A company specializing in the emerging field of nanomedicine has opened in Shelton, offering the possibility that major healthcare advances could be developed in the city.

U.S. Rep. Jim Himes cuts the ribbon at the new NanoViricides facility in Shelton while joined by company officials, including President and Chairman Anil R. Diwan, Interim Chief Financial Officer Meeta Vyas and Chief Executive Officer Eugene Seymour.

The products being produced here could very well end diseases such as influenza and dengue fever, U.S. Rep. Jim Himes said at this weeks opening of the NanoViricides Inc. facility on Controls Drive.

This is truly a game changer for humankind, Himes said.

He predicted the companys president and chairman, Anil R. Diwan, could even win the Nobel Prize in medicine if products now in development at NanoViricides succeed.

Diwan said the firm has six medicines in the pipeline that would treat the flu, dengue, HIV, herpes (cold sores) and eye viruses.

With money raised from investors, NanoViricides has bought the 18,000-square-foot building at 1 Controls Drive, near Long Hill Cross Road. The company is now moving its facilities and employees there from West Haven.

The Shelton site will include manufacturing areas, labs, research-and-development space and offices. The building offers a lot of room for expansion.

It will be the only nanomedicine clinical product manufacturing facility in Connecticut.

Read more from the original source:
Shelton firms products in the pipeline could end diseases